Discovery of 2,9-diaryl-6-carbamoylpurines as a novel class of antitubercular agents

被引:0
|
作者
Correia, Carla [1 ]
Leite, Ana Claudia [1 ,2 ,3 ]
Fraga, Alexandra G. [1 ,2 ,3 ]
Proenca, M. Fernanda [1 ,2 ]
Pedrosa, Jorge [3 ]
Carvalho, M. Alice [1 ]
机构
[1] Univ Minho, CQUM Ctr Chem, Dept Chem, Campus Gualtar, P-4710057 Braga, Portugal
[2] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Braga, Portugal
[3] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal
关键词
Purine derivatives; 6-Carbamoylpurines; New antituberculosis agents; Tuberculosis; Neglected tropical disease; INHIBIT SIDEROPHORE BIOSYNTHESIS; ANTIMYCOBACTERIAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL-ACTIVITY; ANALOGS; SAR; NUCLEOSIDES;
D O I
10.1016/j.ejmech.2024.116297
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 9-alkyl/aryl-2-aryl-6-carbamoylpurines were synthesized, and their activity against Mycobacterium tuberculosis strain H(37)Rv was assessed. The SAR analysis on the first set of derivatives, with an alkyl or aryl unit at N-9 and a phenolic unit at C-2, showed that the activity depends on the purine ring substituents at N-9 and C-2. A phenyl group at N-9 combined with a 3-hydroxyphenyl or 4-hydroxyphenyl at C-2 improve the activity. The most active compound of this set has a phenyl group at N-9 and a 4-hydroxyphenyl group at C-2, displaying an IC90 = 1.2 mu g/mL and a selectivity index higher than 25.5. This compound served as a Hit to design the second set of derivatives. A phenyl group at N-9 was maintained, and the group at C-2 was diversified. The SAR analysis showed that the aryl unit at C-2 must have an oxygen or nitrogen atom bonded in the para position. A proton, a small alkyl or a substituted aryl group may also be bonded to the oxygen. The compound with the 4-methoxyphenyl group at C-2, 1Bd, exhibits the highest activity with an IC90 < 0.19 mu g/mL. This compound is highly potent against M. tuberculosis strain H(37)Rv and non-toxic for VERO mammalian cells with an SI > 153.8. Compound 1Bd was also non-cytotoxic against primary macrophage cultures at IC90, 2xIC(90), and 10xIC(90) and significantly reduced the bacterial load in M. tuberculosis-infected macrophages at the same concentrations. Compound 1Bd showed a favorable pharmacokinetic profile when administered orally, with major lung and liver accumulation. In vivo antimycobacterial efficacy of 1Bd was tested at 25 mg/kg. At the tested regimen, a decrease in bacterial burden was observed in the liver. Optimization of the treatment regimen should be performed to fully potentiate the in vivo efficacy of our lead molecule, particularly in the lung, the main target organ of M. tuberculosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Novel dihydropyrimidines as a potential new class of antitubercular agents
    Trivedi, Amit R.
    Bhuva, Vimal R.
    Dholariya, Bipin H.
    Dodiya, Dipti K.
    Kataria, Vipul B.
    Shah, Viresh H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) : 6100 - 6102
  • [2] Novel 6-Phenylnicotinohydrazide Derivatives: Design, Synthesis and Biological Evaluation as a Novel Class of Antitubercular and Antimicrobial Agents
    Soliman, Dalia Hussein
    Eldehna, Wagdy Mohamed
    Ghabbour, Hazem Ahmed
    Kabil, Maha Mamdouh
    Abdel-Aziz, Marwa Mostafa
    Abdel-Azizh, Hatem Abdel-Kader
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (11) : 1883 - 1893
  • [3] Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
    Chiarelli, Laurent R.
    Mori, Matteo
    Barlocco, Daniela
    Beretta, Giangiacomo
    Gelain, Arianna
    Pini, Elena
    Porcino, Marianna
    Mori, Giorgia
    Stelitano, Giovanni
    Costantino, Luca
    Lapillo, Margherita
    Bonanni, Davide
    Poli, Giulio
    Tuccinardi, Tiziano
    Villa, Stefania
    Meneghetti, Fiorella
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 754 - 763
  • [4] Diaryl naphthyl methanes a novel class of anti-implantation agents
    Srivastava, N
    Ray, SS
    Singh, MM
    Dwivedi, A
    Kumar, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) : 1011 - 1021
  • [5] Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class of Antitubercular Agents
    Kumar, Kunal
    Awasthi, Divya
    Lee, Seung-Yub
    Zanardi, Ilaria
    Ruzsicska, Bela
    Knudson, Susan
    Tonge, Peter J.
    Slayden, Richard A.
    Ojima, Iwao
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 374 - 381
  • [6] Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents
    Ang, Wei
    Ye, Weiwei
    Sang, Zitai
    Liu, Yuanyuan
    Yang, Tao
    Deng, Yong
    Luo, Youfu
    Wei, Yuquan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (06) : 1496 - 1501
  • [7] Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents
    Kancharla, Papireddy
    Ortiz, Diana
    Fargo, Corinne M.
    Zhang, Xiaowei
    Li, Yuexin
    Sanchez, Marco
    Kumar, Amrendra
    Yeluguri, Monish
    Dodean, Rozalia A.
    Caridha, Diana
    Madejczyk, Michael S.
    Martin, Monica
    Jin, Xiannu
    Blount, Cameron
    Chetree, Ravi
    Pannone, Kristina
    Dinh, Hieu T.
    DeLuca, Jesse
    Evans, Martin
    Nadeau, Robert
    Vuong, Chau
    Leed, Susan
    Dennis, William E.
    Roncal, Norma
    Pybus, Brandon S.
    Lee, Patricia J.
    Roth, Alison
    Reynolds, Kevin A.
    Kelly, Jane X.
    Landfear, Scott M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (10) : 8323 - 8345
  • [8] Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents
    Bhukya, Balakishan
    Shukla, Aparna
    Chaturvedi, Vinita
    Trivedi, Priyanka
    Kumar, Shailesh
    Khan, Feroz
    Negi, Arvind S.
    Srivastava, Santosh Kumar
    BIOORGANIC CHEMISTRY, 2020, 99
  • [9] Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents
    Qin, Mingze
    Yan, Shuang
    Wang, Lei
    Zhang, Haotian
    Zhao, Yanfang
    Wu, Shasha
    Wu, Di
    Gong, Ping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 115 : 1 - 13
  • [10] Exploring novel antitubercular agents: Innovative design of 2,3-diaryl-quinoxalines targeting DprE1 for effective tuberculosis treatment
    Sharma, Kirti
    Sharma, Atul
    Sanduja, Mohit
    Jogpal, Vikas
    Mishra, Asim Kumar
    Kumar, Girish
    Virmani, Tarun
    Noman, Omar M.
    Alhalmi, Abdulsalam
    OPEN CHEMISTRY, 2024, 22 (01):